0
Skip to Content
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Economics, Pharma 2/26/07 Economics, Pharma 2/26/07

Wal-Mart rides to the rescue

Read More
Announcements, Entrepreneurs, Pharma 2/15/07 Announcements, Entrepreneurs, Pharma 2/15/07

In good company

Read More
Amusements, Pharma 2/14/07 Amusements, Pharma 2/14/07

Coming soon: The Viagra Monologues?

Read More
Pharma, Policy and politics 2/6/07 Pharma, Policy and politics 2/6/07

Is it racist not to cover BiDil?

Read More
Economics, Pharma 2/1/07 Economics, Pharma 2/1/07

Another angle in the battle over Caremark

Read More
Entrepreneurs, Pharma, Research, Technology 1/30/07 Entrepreneurs, Pharma, Research, Technology 1/30/07

Pfizer and iCardiac announce cardiac safety alliance

Read More
Pharma 1/29/07 Pharma 1/29/07

Drug rep bashing

Read More
Economics, Pharma 1/24/07 Economics, Pharma 1/24/07

Is the time ripe for a big pharma LBO?

Read More
Patients, Pharma, Physicians 1/23/07 Patients, Pharma, Physicians 1/23/07

Wanting more

Read More
Economics, Pharma, Policy and politics 1/12/07 Economics, Pharma, Policy and politics 1/12/07

Could it happen here?

Read More
Economics, Pharma, Physicians 1/8/07 Economics, Pharma, Physicians 1/8/07

Who's afraid of the big bad debate?

Read More
Economics, Patients, Pharma, Policy and politics 1/4/07 Economics, Patients, Pharma, Policy and politics 1/4/07

More secondary drug trading fallout

Read More
Patients, Pharma, Policy and politics, Research 1/2/07 Patients, Pharma, Policy and politics, Research 1/2/07

Suspicious survey

Read More
Economics, International, Pharma 1/1/07 Economics, International, Pharma 1/1/07

Saved by the professors?

Read More
Culture, Pharma, Policy and politics, Research 12/21/06 Culture, Pharma, Policy and politics, Research 12/21/06

More on dextromethorphan

Read More
Hospitals, International, Pharma, Policy and politics, Research 12/20/06 Hospitals, International, Pharma, Policy and politics, Research 12/20/06

The value of private funds for drug research

Read More
Hospitals, Pharma, Physicians, Policy and politics 12/19/06 Hospitals, Pharma, Physicians, Policy and politics 12/19/06

Henry Ford regulates pharma reps

Read More
Pharma, Policy and politics 12/18/06 Pharma, Policy and politics 12/18/06

Missing the point on biogenerics

Read More
Devices, Pharma 12/14/06 Devices, Pharma 12/14/06

You won't have to hide your bong

Read More
Pharma 12/11/06 Pharma 12/11/06

Pharma Pheel Good

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2026 Health Business Group. All Rights Reserved.